Statistics for Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial

Total visits

views
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial 296

Total visits per month

views
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0

File Visits

views
Gane_2016_efficacy.pdf 305
java.util.UUID:18bb4e44-8631-45f9-bb09-8995be59667a 46
java.util.UUID:15acb955-eb1d-4c56-bd33-543a967c7445 15
java.util.UUID:3ce470ed-a303-4ecb-b960-d5f287ebb205 10

Top country views

views
United States 197
Germany 24
China 11
Ukraine 8
United Kingdom 6
Russia 5
Sweden 5
Canada 2
Australia 1
Egypt 1
France 1
Greece 1
Lebanon 1
Lithuania 1
Malaysia 1
Netherlands 1
Philippines 1
Pakistan 1
Poland 1
Portugal 1
Taiwan 1

Top city views

views
Wilmington 52
Fairfield 38
Kiez 19
White Plains 12
Ann Arbor 11
Cambridge 11
Houston 9
Jacksonville 7
Kiev 6
Gunzenhausen 5
Stockholm 4
Washington 4
Beijing 3
Saint Petersburg 3
Brooklyn 2
Chengdu 2
Moscow 2
Norwalk 2
San Francisco 2
Shanghai 2
Alexandria 1
Athens 1
Augusta 1
Beirut 1
Cairo 1
Carbondale 1
Chongqing 1
Coimbra 1
Dniepropetrovsk 1
Fort Washington 1
Henryk 1
Kalmar 1
Karachi 1
Lake Mary 1
Lexington 1
London 1
Makati 1
Montreal 1
Mount Pleasant 1
New York 1
Nijmegen 1
Paris 1
Philadelphia 1
Portland 1
Radcliffe 1
Ridgefield 1
Rockville 1
Scottsdale 1
Seremban 1
Shenzhen 1
Sydney 1
Taipei 1
Toledo 1
Toronto 1
Vilnius 1